TAPIMMUNE INC has a total of 26 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, Canada and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are IST SUPERIORE SANITA, KUMON HIROMI and ALPHA O PEPTIDES AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | Canada | 3 | |
#3 | Australia | 2 | |
#4 | China | 2 | |
#5 | Japan | 2 | |
#6 | Republic of Korea | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Florkiewicz Robert Z | 9 |
#2 | Jefferies Wilfred Arthur | 7 |
#3 | Jefferies Wilfred | 6 |
#4 | Chen Susan Shu-Ping | 5 |
#5 | Vitalis Timothy Z | 5 |
#6 | Choi Kyung Bok | 4 |
#7 | Alimonti Judie Barbara | 4 |
#8 | Zhang Qian-Jin | 3 |
#9 | Basha Genc | 3 |
#10 | Alimonti Judi Barbara | 2 |
Publication | Filing date | Title |
---|---|---|
AU2015231461A1 | Nucleic acid molecule vaccine compositions and uses thereof | |
US2010322963A1 | Low dose inoculation with tap for anti-tumor immunity | |
US2011117137A1 | Tapasin augmentation for enhanced immune response | |
KR20140022430A | Poxviridae treatment comprising tap-1 and/or tap-2 as a molecular adjuvant |